Detalhe da pesquisa
1.
Thyroid dysfunction in COVID-19 patients.
J Endocrinol Invest
; 44(12): 2735-2739, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34101132
2.
Everolimus is a new anti-cancer molecule: Metabolic side effects as lipid disorders and hyperglycemia.
Diabetes Res Clin Pract
; 143: 428-431, 2018 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-29684618
3.
Influence of pyridostigmine on growth hormone (GH) response to GH-releasing hormone pre- and postprandially in normal and obese subjects.
J Clin Endocrinol Metab
; 74(6): 1253-7, 1992 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-1592867
4.
GH response to GHRH before and after meals at different hours of the day in obese patients.
Psychoneuroendocrinology
; 16(4): 361-5, 1991.
Artigo
em Inglês
| MEDLINE | ID: mdl-1745702
5.
Influence of naloxone infusion on prolactin and growth hormone response to growth hormone-releasing hormone in anorexia nervosa.
Psychoneuroendocrinology
; 16(6): 499-504, 1991.
Artigo
em Inglês
| MEDLINE | ID: mdl-1811245
6.
Acromegalic cardiomyopathy. Left ventricular filling and hypertrophy in active and surgically treated disease.
Chest
; 102(4): 1204-8, 1992 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-1395769
7.
Opioid dysregulation in anorexia nervosa: naloxone effects on preprandial and postprandial growth hormone response to growth hormone-releasing hormone.
Metabolism
; 43(2): 140-3, 1994 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-8121292
8.
Preoperative growth hormone response to thyrotropin-releasing hormone and oral glucose tolerance test in acromegaly: a retrospective evaluation of 50 patients.
Metabolism
; 51(5): 616-21, 2002 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-11979395
9.
Sex-related naloxone influence on growth hormone-releasing hormone-induced growth hormone secretion in normal subjects.
Metabolism
; 36(2): 105-9, 1987 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-3100909
10.
Naloxone influence on the growth hormone, prolactin and thyrotropin response to thyrotropin releasing hormone in acromegalic patients.
Exp Clin Endocrinol Diabetes
; 104(1): 67-71, 1996.
Artigo
em Inglês
| MEDLINE | ID: mdl-8750573
11.
Primary hyperparathyroidism. Our experience.
Minerva Endocrinol
; 16(3): 107-11, 1991.
Artigo
em Inglês
| MEDLINE | ID: mdl-1806807
12.
[Reevaluation of the I-dopa test in acromegaly: anatomo-clinical and prognostic correlations]. / Rivalutazione del test alla I-dopa nell'acromegalia: correlazioni anatomo-cliniche e prognostiche.
Minerva Chir
; 48(21-22): 1337-40, 1993 Nov.
Artigo
em Italiano
| MEDLINE | ID: mdl-8152567
13.
[Thyroid metastasis of a renal carcinoma. 3 clinical cases]. / Metastasi tiroidea di carcinoma renale. Tre casi clinici.
Chir Ital
; 52(6): 719-23, 2000.
Artigo
em Italiano
| MEDLINE | ID: mdl-11200010
14.
[Long-term anticonvulsant therapy and calcium and phosphorus metabolism]. / Terapia cronica anticomiziale e metabolismo calcio-fosforico.
Riv Neurol
; 49(1): 72-81, 1979.
Artigo
em Italiano
| MEDLINE | ID: mdl-451400
15.
Cardiovascular reactivity and plasma prolactin response to mental stress in normals and hypertensives.
Clin Exp Hypertens A
; 11(2): 277-93, 1989.
Artigo
em Inglês
| MEDLINE | ID: mdl-2650930
16.
Paradoxical growth hormone response to thyrotropin-releasing hormone in acromegaly. Clinical correlations and prognostic value.
Acta Endocrinol (Copenh)
; 122(4): 443-9, 1990 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-2110409
17.
Calcium antagonists and hormone release. VIII. Effects of verapamil infusion on C-peptide to insulin molar ratio in normal subjects and obese subjects with normal glucose tolerance.
Diabetes Res
; 19(1): 9-16, 1992 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-1468187
18.
Opioid-dopaminergic interactions in primary empty sella.
Exp Clin Endocrinol
; 101(5): 277-82, 1993.
Artigo
em Inglês
| MEDLINE | ID: mdl-8299703
19.
Naloxone effects on post-prandial glucose, insulin and C-peptide levels in obese subjects.
Diabetes Res
; 23(2): 83-91, 1993.
Artigo
em Inglês
| MEDLINE | ID: mdl-7712683
20.
Calcium antagonists and hormone release. VII. Effects of gallopamil infusion on insulin and C peptide release in normal subjects.
Diabetes Res
; 17(2): 93-7, 1991 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-1817816